Cargando…
Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies
IgG Fc-glycans affect IgG function and are altered in autoimmune diseases and autoantibodies. Anti-histidyl tRNA synthetase autoantibodies (anti-Jo1) are frequent in patients with idiopathic inflammatory myopathies (IIM) and anti-synthetase syndrome (ASS) with associated interstitial lung disease (I...
Autores principales: | Fernandes-Cerqueira, Cátia, Renard, Nuria, Notarnicola, Antonella, Wigren, Edvard, Gräslund, Susanne, Zubarev, Roman A., Lundberg, Ingrid E., Lundström, Susanna L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298993/ https://www.ncbi.nlm.nih.gov/pubmed/30560888 http://dx.doi.org/10.1038/s41598-018-36395-z |
Ejemplares similares
-
Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome
por: Notarnicola, Antonella, et al.
Publicado: (2022) -
Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis
por: Kryštůfková, Olga, et al.
Publicado: (2018) -
Jo Coenen
Publicado: (1995) -
Anti-Jo-1 autoantibodies: biomarkers of severity and evolution of the disease in antisynthetase syndrome
por: Arcani, Robin, et al.
Publicado: (2023) -
On the groups JO(G)
por: Lee, Chung-Nim, et al.
Publicado: (1975)